In terms of the Covaxin clearance, we know scientific data, public health considerations, international health requirements are all considered. All these (data) have been provided to the WHO, which will decide on the matter.
Data has been given on which clearance is given by WHO. The data is being looked at, WHO to take a decision (on Covaxin clearance).
Since this (Zydus) is a three-dose vaccine and involves a needle-less delivery system, it will have a differential pricing system than the existing vaccines in the Covid vaccination programme.
Dengue vaccine is an important agenda. There are certain dengue strains which have been licensed to some companies in India. Many of these companies have done their phase one trials abroad. We are planning to do more rigourous trials.
As festivals are approaching, we appeal to all to avoid crowds, maintain physical distancing and use face mask. Celebrate festivals maintaining Covid-19 appropriate behaviour